We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.4B
AUM Growth
+$49.9M
(+0.3%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
1,532
New
77
Increased
144
Reduced
521
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coty
COTY
|
+$139M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$38M |
| 3 |
GCP
GCP Applied Technologies Inc.
GCP
|
+$34.7M |
| 4 |
Sonida Senior Living
SNDA
|
+$25.5M |
| 5 |
Theravance Biopharma
TBPH
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$68M |
| 2 |
ConocoPhillips
COP
|
+$44.3M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$35.7M |
| 4 |
Zimmer Biomet
ZBH
|
+$33.7M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.47% |
| 2 | Healthcare | 12.64% |
| 3 | Industrials | 9.32% |
| 4 | Technology | 8.7% |
| 5 | Consumer Staples | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Valley National Bancorp
VLY
$7.93B
| $1.04M | 0.01% |
89,175
+170
| +0.2% | +$1.82K |
|
402
Golar LNG
GLNG
$4.95B
| $1.03M | 0.01% |
45,150
-4,000
| -8% | -$93K |
|
|
ESND
403
DELISTED
Essendant Inc.
ESND
| $1.03M | 0.01% |
49,491
-397,680
| -89% | -$7.56M |
|
|
SHYF
404
DELISTED
The Shyft Group
SHYF
| $1.03M | 0.01% |
111,315
-11,700
| -10% | -$105K |
|
|
VIA
405
DELISTED
Viacom Inc. Class A
VIA
| $1.02M | 0.01% |
26,460
-2,005
| -7% | -$82.2K |
|
406
Goldman Sachs
GS
$313B
| $1M | 0.01% |
4,187
-49
| -1% | -$9.95K |
|
407
TJX Companies
TJX
$170B
| $992K | 0.01% |
26,410
-8,010
| -23% | -$303K |
|
408
General Dynamics
GD
$105B
| $985K | 0.01% |
5,708
-359
| -6% | -$58.7K |
|
409
Liberty Latin America Class A
LILA
$1.51B
| $985K | 0.01% |
70,051
-511
| -0.7% | -$7.77K |
|
410
Mastercard
MA
$477B
| $978K | 0.01% |
9,481
+2,058
| +28% | +$213K |
|
411
Ark Restaurants
ARKR
| $954K | 0.01% |
39,350
| – | – |
|
|
PXD
412
DELISTED
Pioneer Natural Resource Co.
PXD
| $952K | 0.01% |
5,287
| – | – |
|
413
Tootsie Roll Industries
TR
$2.82B
| $939K | 0.01% |
31,749
| – | – |
|
414
PG&E
PCG
$47.8B
| $926K | 0.01% |
15,250
-1,500
| -9% | -$89.9K |
|
|
ETP
415
DELISTED
Energy Transfer Partners L.p.
ETP
| $925K | 0.01% |
25,856
-871
| -3% | -$31.1K |
|
|
NVO
416
Novo Nordisk
NVO
$216B
| $923K | 0.01% |
51,524
| – | – |
|
417
W.P. Carey
WPC
$17.1B
| $921K | 0.01% |
15,928
-102
| -0.6% | -$5.96K |
|
|
OME
418
DELISTED
Omega Protein
OME
| $914K | 0.01% |
36,500
| – | – |
|
|
CLSD
419
DELISTED
Clearside Biomedical
CLSD
| $894K | 0.01% |
+6,667
| New | +$1.67M |
|
420
Enviri
NVRI
$621M
| $876K | 0.01% |
64,467
-43,683
| -40% | -$524K |
|
421
Buckle
BKE
$2.19B
| $869K | 0.01% |
38,130
-5,500
| -13% | -$126K |
|
422
Lumen
LUMN
$6.53B
| $869K | 0.01% |
36,573
-645
| -2% | -$16.4K |
|
423
Marathon Petroleum
MPC
$90.3B
| $857K | 0.01% |
17,022
-511
| -3% | -$23.2K |
|
424
State Street
STT
$50.9B
| $855K | 0.01% |
11,004
-125
| -1% | -$9.41K |
|
|
LGF.B
425
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $845K | 0.01% |
+34,437
| New | +$879K |
|
Similar funds
SAM
First Manhattan's Q4 2016 Portfolio in Review
As of Q4 2016, First Manhattan held 1,532 positions worth $16.4B, up 0.3% from $16.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
First Manhattan's Q4 2016 filing shows 77 new, 144 increased, 521 reduced and 96 closed positions. Its largest new stake was Coty: 6,723,666 shares worth $123M. The largest sale was Allergan plc, an estimated $68M.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q4 2016 buy was Coty: 6,723,666 shares worth $123M.
- First Manhattan added most to Teva Pharmaceuticals in Q4 2016, an estimated $38M increase.
- First Manhattan's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $68M.
- First Manhattan fully exited Starz - Series A in Q4 2016, selling an estimated $2.9M.
- First Manhattan's ten largest holdings make up 44% of its $16.4B portfolio in Q4 2016.
- First Manhattan opened 77 new positions and closed 96 in Q4 2016.
- First Manhattan's portfolio value rose 0.3% quarter-over-quarter to $16.4B.
Based on First Manhattan's 13F filing for Q4 2016, filed 25 Jan 2017.